MedX Health Corp. (MDXHF) vs Myriad Genetics, Inc. (MYGN)
- MedX Health Corp. MDXHF 0.03 0.00%
- Myriad Genetics, Inc. MYGN 3.98 −8.51%
MedX Health Corp. and Myriad Genetics, Inc. are both Diagnostics & Research companies. Myriad Genetics, Inc. is the larger, with a market value of $416.1M against $103.2M — 4.0× the size. MedX Health Corp. grew revenue faster over the last twelve months: 20.1% against −3.16%. Myriad Genetics, Inc. has the higher net margin (−14.0% vs −1,087.8%) and the lower return on invested capital (−19.9% vs 0.00%). Across the 17 metrics below, Myriad Genetics, Inc. leads on 11 and MedX Health Corp. on 6.
Valuation
Profitability
| Metric | MDXHF | MYGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | (1.89%) | 68.83% | 50.89% |
| Operating margin | (753.38%) | (12.22%) | (8.57%) |
| Net margin | (1,087.83%) | (13.96%) | (6.37%) |
| Free cash flow margin | (655.93%) | (1.76%) | 0.00% |
| Return on equity | 63.71% | (32.54%) | (2.92%) |
| Return on assets | (840.71%) | (17.11%) | (6.71%) |
| Return on invested capital | 0.00% | (19.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack